Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India
This study highlights genotype-specific variations in treatment response, with GT-3b exhibiting lower treatment response which highlights the need to decipher the reasons behind treatment failure for future therapeutic management.
Authors
- Supradip Dutta (ORCID: https://orcid.org/0000-0003-2516-5146)
- Raina Das (ORCID: https://orcid.org/0000-0002-5588-5526)
- Provash Chandra Sadhukhan (ORCID: https://orcid.org/0000-0002-7014-0530)
- Prosanto Kumar Chowdhury (ORCID: https://orcid.org/0000-0003-2955-7470)
- Moumita Majumdar (ORCID: https://orcid.org/0000-0001-5582-3475)
- Sagnik Bakshi (ORCID: https://orcid.org/0000-0002-3332-2052)
- Upasana Baskey (ORCID: https://orcid.org/0000-0001-6363-886X)
- Shreyasi Nath (ORCID: https://orcid.org/0000-0002-9537-2346)
- A. Ghosh (ORCID: https://orcid.org/0009-0008-0345-1321)
Institutions
- Indian Council of Medical Research (IN)
- National Institute of Cholera and Enteric Diseases (IN)
- Peerless Hospital & B.K.Roy Research Centre (IN)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1186/s12879-025-11565-3
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00